APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sialylated Human Milk Oligosaccharides (HMO)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sialylated Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026

4 July 2026195 pages

Choose your research edition.

Industry ResearchSialylated Human Milk Oligosaccharides (HMO) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sialylated Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Sialylated Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sialylated Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sialylated Human Milk Oligosaccharides (HMO) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sialylated Human Milk Oligosaccharides (HMO) market include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sialylated Human Milk Oligosaccharides (HMO) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sialylated Human Milk Oligosaccharides (HMO) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sialylated Human Milk Oligosaccharides (HMO) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sialylated Human Milk Oligosaccharides (HMO) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sialylated Human Milk Oligosaccharides (HMO) Segment by Company

Chr. Hansen (Jennewein Biotechnologie GmgH)

DSM (Glycom A/S)

Inbiose

Kyowa Hakko Bio

GeneChem Inc.

FrieslandCampina Ingredients

Sialylated Human Milk Oligosaccharides (HMO) Segment by Type

3'-Sialyllactose

6'-Sialyllactose

Sialylated Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Food

Others

Sialylated Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sialylated Human Milk Oligosaccharides (HMO) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sialylated Human Milk Oligosaccharides (HMO) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sialylated Human Milk Oligosaccharides (HMO) significant trends, drivers, influence factors in global and regions.

6. To analyze Sialylated Human Milk Oligosaccharides (HMO) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sialylated Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sialylated Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sialylated Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sialylated Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sialylated Human Milk Oligosaccharides (HMO) industry.

Chapter 3: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sialylated Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sialylated Human Milk Oligosaccharides (HMO) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sialylated Human Milk Oligosaccharides (HMO) Industry Trends Table 2. Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers Table 3. Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 4. Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Company (2021-2026) Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Company (t) & (2021-2026) Table 8. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Company (2021-2026) Table 9. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (USD/t) of Company (2021-2026) Table 10. Global Sialylated Human Milk Oligosaccharides (HMO) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sialylated Human Milk Oligosaccharides (HMO) Key Company Manufacturing Base & Headquarters Table 12. Global Sialylated Human Milk Oligosaccharides (HMO) Company, Product Type & Application Table 13. Global Sialylated Human Milk Oligosaccharides (HMO) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sialylated Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 3'-Sialyllactose Table 18. Significant Companies of 6'-Sialyllactose Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021-2026) & (t) Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type (2027-2032) & (t) Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2026) Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2027-2032) Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2026) Table 28. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Infant Formula Table 30. Significant Companies of Food Table 31. Significant Companies of Others Table 32. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021-2026) & (t) Table 34. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application (2027-2032) & (t) Table 35. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2026) Table 36. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2027-2032) Table 37. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2026) Table 41. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2027-2032) Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (t) Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (t) Table 46. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2027-2032) Table 47. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Region (2021-2026) Table 50. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Region (2027-2032) Table 52. Global Sialylated Human Milk Oligosaccharides (HMO) Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Sialylated Human Milk Oligosaccharides (HMO) Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 57. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 58. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 59. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2027-2032) Table 60. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Market Share by Country (2021-2026) Table 62. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Market Share by Country (2027-2032) Table 64. Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information Table 65. Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview Table 66. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 68. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Development Table 69. DSM (Glycom A/S) Company Information Table 70. DSM (Glycom A/S) Business Overview Table 71. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 73. DSM (Glycom A/S) Recent Development Table 74. Inbiose Company Information Table 75. Inbiose Business Overview Table 76. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 78. Inbiose Recent Development Table 79. Kyowa Hakko Bio Company Information Table 80. Kyowa Hakko Bio Business Overview Table 81. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 83. Kyowa Hakko Bio Recent Development Table 84. GeneChem Inc. Company Information Table 85. GeneChem Inc. Business Overview Table 86. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 88. GeneChem Inc. Recent Development Table 89. FrieslandCampina Ingredients Company Information Table 90. FrieslandCampina Ingredients Business Overview Table 91. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 93. FrieslandCampina Ingredients Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Sialylated Human Milk Oligosaccharides (HMO) Distributors List Table 97. Sialylated Human Milk Oligosaccharides (HMO) Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Product Image Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (t) Figure 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 3'-Sialyllactose Image Figure 10. 6'-Sialyllactose Image Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2032) Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2032) Figure 17. Infant Formula Image Figure 18. Food Image Figure 19. Others Image Figure 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2032) Figure 23. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2032) Figure 26. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sialylated Human Milk Oligosaccharides (HMO) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sialylated Human Milk Oligosaccharides (HMO) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 3'-Sialyllactose
  • 6'-Sialyllactose
Applications
  • Infant Formula
  • Food
  • Others
Companies covered
  • Chr. Hansen (Jennewein Biotechnologie GmgH)
  • DSM (Glycom A/S)
  • Inbiose
  • Kyowa Hakko Bio
  • GeneChem Inc.
  • FrieslandCampina Ingredients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  4. 1.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume (2021-2032)
  5. 1.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sialylated Human Milk Oligosaccharides (HMO) Market Dynamics
  1. 2.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints
3 Sialylated Human Milk Oligosaccharides (HMO) Market by Company
  1. 3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Company Revenue Ranking in 2025
  2. 3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026)
  3. 3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Company (2021-2026)
  4. 3.4 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Company (2021-2026)
  5. 3.5 Global Sialylated Human Milk Oligosaccharides (HMO) Company Ranking (2024-2026)
  6. 3.6 Global Sialylated Human Milk Oligosaccharides (HMO) Company Manufacturing Base and Headquarters
  7. 3.7 Global Sialylated Human Milk Oligosaccharides (HMO) Company Product Type and Application
  8. 3.8 Global Sialylated Human Milk Oligosaccharides (HMO) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sialylated Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sialylated Human Milk Oligosaccharides (HMO) Market by Type
  1. 4.1 Sialylated Human Milk Oligosaccharides (HMO) Type Introduction
  2. 4.1.1 3'-Sialyllactose
  3. 4.1.2 6'-Sialyllactose
  4. 4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type
  5. 4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type
  9. 4.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2032)
5 Sialylated Human Milk Oligosaccharides (HMO) Market by Application
  1. 5.1 Sialylated Human Milk Oligosaccharides (HMO) Application Introduction
  2. 5.1.1 Infant Formula
  3. 5.1.2 Food
  4. 5.1.3 Others
  5. 5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application
  6. 5.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application
  10. 5.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2032)
6 Sialylated Human Milk Oligosaccharides (HMO) Regional Sales and Value Analysis
  1. 6.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2032)
  3. 6.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021-2026
  4. 6.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032)
  5. 6.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Region (2027-2032)
  9. 6.5 Global Sialylated Human Milk Oligosaccharides (HMO) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  12. 6.6.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  15. 6.7.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  21. 6.9.2 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
7 Sialylated Human Milk Oligosaccharides (HMO) Country-level Sales and Value Analysis
  1. 7.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  4. 7.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  5. 7.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032)
  6. 7.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
  2. 8.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information
  3. 8.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview
  4. 8.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 8.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments
  7. 8.2 DSM (Glycom A/S)
  8. 8.2.1 DSM (Glycom A/S) Company Information
  9. 8.2.2 DSM (Glycom A/S) Business Overview
  10. 8.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 8.2.5 DSM (Glycom A/S) Recent Developments
  13. 8.3 Inbiose
  14. 8.3.1 Inbiose Company Information
  15. 8.3.2 Inbiose Business Overview
  16. 8.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 8.3.5 Inbiose Recent Developments
  19. 8.4 Kyowa Hakko Bio
  20. 8.4.1 Kyowa Hakko Bio Company Information
  21. 8.4.2 Kyowa Hakko Bio Business Overview
  22. 8.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 8.4.5 Kyowa Hakko Bio Recent Developments
  25. 8.5 GeneChem Inc.
  26. 8.5.1 GeneChem Inc. Company Information
  27. 8.5.2 GeneChem Inc. Business Overview
  28. 8.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 8.5.5 GeneChem Inc. Recent Developments
  31. 8.6 FrieslandCampina Ingredients
  32. 8.6.1 FrieslandCampina Ingredients Company Information
  33. 8.6.2 FrieslandCampina Ingredients Business Overview
  34. 8.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 8.6.5 FrieslandCampina Ingredients Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sialylated Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 9.1.1 Sialylated Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sialylated Human Milk Oligosaccharides (HMO) Sales Mode & Process
  6. 9.2 Sialylated Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
  9. 9.2.3 Sialylated Human Milk Oligosaccharides (HMO) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst